Immediate Impact
2 by Nobel laureates 2 from Science/Nature 54 standout
Citing Papers
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
Polymeric Nanoparticles for Drug Delivery
2024 Standout
Works of Peter Kelley being referenced
Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
2014
Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter Kelley | 139 | 110 | 201 | 17 | 353 | |
| Monique Twynholm | 150 | 83 | 178 | 11 | 386 | |
| D. Roscoe | 140 | 97 | 167 | 15 | 408 | |
| Steven D. Dallas | 136 | 95 | 194 | 21 | 386 | |
| Mustafa Samastı | 67 | 90 | 159 | 15 | 314 | |
| Hideji Yanagisawa | 141 | 115 | 136 | 19 | 369 | |
| Yusuke Ainoda | 134 | 69 | 165 | 28 | 342 | |
| H. Aubry‐Damon | 86 | 113 | 264 | 10 | 402 | |
| Benedict L. Wasilauskas | 187 | 116 | 94 | 38 | 408 | |
| P. Gialanella | 161 | 95 | 287 | 12 | 396 | |
| Michel Auzou | 117 | 147 | 195 | 24 | 408 |
All Works
Login with ORCID to disown or claim papers
Loading papers...